Vyne Therapeutics Inc (VYNE) financials · rev $570.0K
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Vyne Therapeutics Inc (VYNE) rev $570.0K.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $570.0K | $501.0K |
| Operating Income | -$29.7M | -$43.6M |
| Net Income | -$26.5M | -$39.8M |
| EPS (Diluted) | -$0.62 | -$0.93 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $30.2M | $66.9M |
| Current Assets | $30.0M | $64.4M |
| Cash & Equivalents | $24.0M | $19.9M |
| PP&E | $90.0K | $113.0K |
| Total Liabilities | $2.40M | $14.8M |
| Current Liabilities | $2.40M | $14.8M |
| Long-term Debt | N/A | N/A |
| Shareholders' Equity | $27.8M | $52.1M |
| Retained Earnings | -$757.7M | -$731.2M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$33.1M | -$34.0M |
| CapEx | N/A | $117.0K |
| Investing Cash Flow | $37.4M | $23.4M |
| Financing Cash Flow | -$143.0K | -$141.0K |
| Net Change in Cash | $4.10M | -$10.7M |
| Free Cash Flow | -$33.1M | -$34.1M |
FAQ
What is VYNE P/E and revenue?
Vyne Therapeutics Inc (VYNE) rev $570.0K.
What is VYNE revenue?
Vyne Therapeutics Inc last cached revenue is $570.0K (FY2025).
Is VYNE profitable?
Vyne Therapeutics Inc last cached net income is -$26.5M (FY2025).
What are VYNE total assets?
Vyne Therapeutics Inc last cached total assets are $30.2M (FY2025).
What is VYNE free cash flow?
Vyne Therapeutics Inc last cached free cash flow is -$33.1M (FY2025).
Not investment advice. Cached statements, not a live tape.